97 related articles for article (PubMed ID: 1537778)
21. Comparative studies of pharmacotherapy for school refusal.
Bernstein GA; Garfinkel BD; Borchardt CM
J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):773-81. PubMed ID: 2228932
[TBL] [Abstract][Full Text] [Related]
22. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study].
Bernardi F; Fossi L; Faravelli C; Corsini GU; Varricchio MC
Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441
[TBL] [Abstract][Full Text] [Related]
23. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam.
Snyder PJ; Werth J; Giordani B; Caveney AF; Feltner D; Maruff P
Hum Psychopharmacol; 2005 Jun; 20(4):263-73. PubMed ID: 15912482
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
Hoehn-Saric R; McLeod DR; Zimmerli WD
J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
[TBL] [Abstract][Full Text] [Related]
26. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
28. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
[TBL] [Abstract][Full Text] [Related]
29. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
Pyke RE; Greenberg HS
J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
[TBL] [Abstract][Full Text] [Related]
30. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
Charney DS; Woods SW
J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
[TBL] [Abstract][Full Text] [Related]
31. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
[TBL] [Abstract][Full Text] [Related]
32. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
Ruiz AT
J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
[TBL] [Abstract][Full Text] [Related]
33. A neurophysiological study of the detrimental effects of alprazolam on human action monitoring.
Riba J; Rodríguez-Fornells A; Münte TF; Barbanoj MJ
Brain Res Cogn Brain Res; 2005 Oct; 25(2):554-65. PubMed ID: 16168630
[TBL] [Abstract][Full Text] [Related]
34. [Clinical use of sustained release of alprazolam: A naturalistic study].
De La Gándara Martín JJ; Sanz Granado O; Varona Martínez A; Such P
Actas Esp Psiquiatr; 1999; 27(3):191-7. PubMed ID: 10431062
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
[TBL] [Abstract][Full Text] [Related]
36. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
Pols H; Verburg K; Hauzer R; Meijer J; Griez E
Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
[TBL] [Abstract][Full Text] [Related]
37. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
[TBL] [Abstract][Full Text] [Related]
38. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
[TBL] [Abstract][Full Text] [Related]
39. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
[TBL] [Abstract][Full Text] [Related]
40. Treatment effects of alprazolam and imipramine: physiological versus subjective changes in patients with generalized anxiety disorder.
McLeod DR; Hoehn-Saric R; Zimmerli WD; De Souza EB; Oliver LK
Biol Psychiatry; 1990 Nov; 28(10):849-61. PubMed ID: 2268689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
